Tetsutaro Hamano

Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer

Takako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano et al. · Cancer Science · 2010 · 222 citations · Full text

Colorectal Adenoma, Chemoprevention Strategy, Pathology +22

Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer

Takako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano et al. · Journal of Gastroenterology · 2009 · 179 citations

Obesity, Metabolic Syndrome, Medicine +10

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

Toru Sugiyama, Aikou Okamoto, Takayuki Enomoto et al. · Journal of Clinical Oncology · 2016 · 139 citations

Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: Efficacy and toxicity of a low cumulative radiation dose schedule

Takafumi Toita, Ryo Kitagawa, Tetsutaro Hamano et al. · Gynecologic Oncology · 2012 · 110 citations

Concurrent Chemoradiotherapy, High-dose-rate Intracavitary Brachytherapy, Cervical Cancer +8

Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples

Yasuhide Yamada, Tokuzo Arao, Takuji Gotoda et al. · Cancer Science · 2008 · 81 citations · Full text